Clinical Trial

Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction

Study acronym: INSIGHT
Recruiting
View on ClinicalTrials.gov →
Summary
This study is a randomized cross-over trial comparing AIDANET with Anticipation to AIDANET in FCL without Anticipation. Participants will complete 4 weeks of AID data collection which will be used to establish baseline and initialize the control algorithm. Participants will then be randomized to one of two groups: Group A: AIDANET in FCL with Anticipation (AIDANET+ACL), and Group B: AIDANET in FCL without Anticipation (AIDANET+FCL). The study duration of each group is 4 weeks each. The order of these two phases will be dependent upon randomization.
Protocol Amendment History 6 changes
critical Trial status changed: Withheld → Recruiting 2026-06-23
critical Phase changed: not specified -> not applicable 2026-06-23
critical Primary endpoint(s) modified 2026-06-23
notable Enrollment changed: None -> 20 2026-06-23
notable Sponsor changed: [Redacted] -> Sue Brown 2026-06-23
minor Trial arms changed: 0 -> 2 2026-06-23
Trial Details
NCT Number NCT07507708
Lead Sponsor Sue Brown
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Tandem Diabetes Care, Inc., DexCom, Inc.
Conditions Type 1 Diabetes (T1D)
Enrollment 20 participants
Start Date 2026-05-14
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-06-22